Travel Vaccines and Elderly Persons: Review of Vaccines Available in the United States
作者： Karin Leder , Peter F. Weller , Mary E. Wilson
DOI: 10.1086/322968
关键词:
摘要: Aging is associated with alterations in immune responses and may lead to clinically significant changes the safety, immunogenicity, protective efficacy of certain vaccines. This review summarizes published data regarding effects age on after immunization vaccines generally administered before travel. The specific discussed detail include hepatitis A, typhoid, yellow fever, Japanese encephalitis, rabies There some evidence diminished serological A older individuals. In addition, increased toxic following fever vaccination elderly recipients have recently been reported. However, many travel-related never studied specifically populations. Consideration potential age-related differences travel becoming increasingly important as persons more frequently venture exotic destinations.
oup.com
paperity.org
oxfordjournals.org参考文章(124)
Urasawa S, Katsurada M, Kimura H, Hashimoto N, Kanamitsu M, A field trial with an improved Japanese encephalitis vaccine in a nonendemic area of the disease. Biken's Journal. ,vol. 13, pp. 313- 328 ,(1970)
David R. Hill, Pre-travel health, immunization status, and demographics of travel to the developing world for individuals visiting a travel medicine service. American Journal of Tropical Medicine and Hygiene. ,vol. 45, pp. 263- 270 ,(1991) , 10.4269/AJTMH.1991.45.263
D. J. Vugia, S. B. Werner, M. E. Guroy, F. Schwartz, F. Drach, J. Olson, J. Rabban, H. Sanchez, M. S. Ascher, C. A. Glaser, Fatal yellow fever in a traveler returning from Venezuela, 1999. Morbidity and Mortality Weekly Report. ,vol. 49, pp. 303- 305 ,(2000)
T. D. Mastro, S. Chearskul, T. Chotpitayasunondh, P. Mock, N. Waranawat, N. Shaffer, P. Yuentrakul, T. F. Tsai, S. Rojanasuphot, S. Phumiamorn, Response to JE vaccine among HIV-infected children, Bangkok, Thailand. Southeast Asian Journal of Tropical Medicine and Public Health. ,vol. 29, pp. 443- 450 ,(1998)
Pond Wl, Danauskas Jx, Ehrenkranz Nj, Carter Mj, Heterotypic Serologic Responses after Yellow Fever Vaccination; Detection of Persons with Past St. Louis Encephalitis or Dengue Journal of Immunology. ,vol. 98, pp. 673- 682 ,(1967)
Werner J, Iwand A, Kuwert Ek, Marcus I, Thraenhart O, Some experiences with human diploid cell strain-(HDCS) rabies vaccine in pre- and post-exposure vaccinated humans. Developments in biological standardization. ,vol. 40, pp. 79- 88 ,(1978)
S J Cryz, N Vanprapar, U Thisyakorn, T Olanratmanee, G Losonsky, M M Levine, S Chearskul, Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children. Infection and Immunity. ,vol. 61, pp. 1149- 1151 ,(1993) , 10.1128/IAI.61.3.1149-1151.1993
T P Monath, K Murphy, W G Downs, J D Poland, C H Calisher, Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine Bulletin of The World Health Organization. ,vol. 59, pp. 895- 900 ,(1981)
Joy M. McFarland, Larry M. Baddour, Jeffery E. Nelson, Sandra K. Elkins, Robert B. Craven, Bruce C. Cropp, Gwong‐Jen Chang, Alan D. Grindstaff, Allen S. Craig, Russell J. Smith, Imported yellow fever in a United States citizen Clinical Infectious Diseases. ,vol. 25, pp. 1143- 1147 ,(1997) , 10.1086/516111
D. W. Scheifele, G. J. Bjornson, Evaluation of inactivated hepatitis A vaccine in Canadians 40 years of age or more. Canadian Medical Association Journal. ,vol. 148, pp. 551- 555 ,(1993)